iGHP Special Lecture series"How Does Politics Influence Global Health Policy?
Antimicrobial Resistance (AMR) and Pandemic Influenza"
Institute for Global Health Policy Research (iGHP), the Bureau of International
Health Cooperation, in joint collaboration with the Disease Control and Prevention
Center (DCC) of National Center for Global Health and Medicine (NCGM), is
pleased to announce the upcoming seminar entitled, "How Does Politics Influence
Global Health Policy?: AMR and Pandemic Influenza", which is to be held onFebruary 27, 2018 in Tokyo.
The seminar includes a special lecture by Professor Keiji Fukuda, the Director andClinical Professor at the University of Hong Kong School of Public Health, and apanel discussion with Japanese leading experts in the fields of infectious diseases
and epidemiology who have extensive knowledge and experiences in clinicalpractice, research, education, and domestic and international health policy.

1. Seminar Details
Date & Time

Tuesday, February 27, 2018, 17:00-19:00

Venue

Institute for Global Health Policy Research, Bureau ofInternational Cooperation (Ground floor, Training Center
Building), National Center for Global Health and Medicine,TokyoAccess

http://kyokuhp.ncgm.go.jp/eng/aboutus/access.html

Language

English only (No Japanese interpretation will be available)

Participation

Free of charge and open to general public, and a light meal will
be provided.

Seating capacity

Approximately 80

2. Agenda (tentative)

17:00-17:05

Welcome Remarks (Kenji Shibuya, Director, Institute for Global
Health Policy Research, NCGM)

17:05-17:10

Opening Remarks (Kuniaki Miyake, Director, Tuberculosis andInfectious Diseases Control Division, Health Service Bureau,
MOHLW, Japan)

17:10-18:00

Special Lecture followed by a Q&A session (Keiji Fukuda, Directorand Clinical Professor, School of Public Health, the University ofHong Kong)

18:00-18:45

Panel Discussion
Moderator:•Makoto Aoki, Free-lance infectious disease consultant, Adjunct
Professor of Medicine, Tokyo Medical UniversityPanelists:•Keiji Fukuda, Director and Clinical Professor, School of Public
Health, the University of Hong Kong

•Kiyosu Taniguchi, Director, Department of Clinical Research,National Mie Hospital, National Hospital Organization, Mie,Japan•

Kentaro Iwata, Professor, Kobe University Graduate School ofMedicine and Chief, Division of Infectious Diseases and Divisionof International Healthcare, Kobe University Hospital, Hyogo,
Japan•Hajime Kamiya, Senior Researcher, Medical Officer, Infectious
Disease Surveillance Center, National Institute of Infectious
Diseases, Tokyo, Japan

18:45-18:55

Q & A Session

18:55-19:00

Closing Remarks (Norio Ohmagari, Director, Disease Control andPrevention Center, NCGM)

About the Speakers:
Keiji Fukuda, MD, MPH

Keiji Fukuda is the Director and a Clinical Professor at The University of Hong Kong
School of Public Health. He previously worked at the World Health Organization(WHO) in several capacities including Assistant Director-General (ADG) and Special
Representative of the Director-General for antimicrobial resistance; ADG for theHealth Security and Environment Cluster; and Director of the Global Influenza
Programme. Before that, he worked at the U.S. Centers for Disease Control andPrevention (CDC) as the Epidemiology Section Chief, Influenza Branch and as a
Medical Epidemiologist in the Viral Exanthems and Herpesvirus Branch, National
Center for Infectious Diseases.
Professor Fukuda has been a global public health leader in many areas including
health security; emerging infectious diseases including seasonal, avian andpandemic influenza, SARS, MERS and Ebola; antimicrobial resistance; developmentof the Pandemic Influenza Preparedness Framework; implementation of theInternational Health Regulations; food safety; and chronic fatigue syndrome. He has
considerable experience in epidemiological research and field investigations, media
communications and international diplomatic negotiations including those held toestablish a historic Heads of State level meeting on antimicrobial resistance at theUnited Nations in 2016.
He has a BA in Biology, an MD; an MPH; was trained in the Epidemic Intelligence
Service at CDC and is certified in internal medicine by the American Board ofInternal Medicine.

Makoto Aoki, MD, FACP, FIDSA

Dr. Aoki is a free-lance infectious disease consultant, and also serves as theAdjunct Professor of Medicine, Tokyo Medical University.
He received his MD degree from Hirosaki University School of Medicine in 1979. Hecompleted internal medicine residency in the University of Kentucky School ofMedicine followed by an infectious disease fellowship in 1992. He is board-certified
in internal medicine and infectious diseases in the United States.
After completion of his fellowship, Dr. Aoki returned to Japan to provide clinicalinfectious diseases practice at the beginning of the HIV epidemic era in Japan. He
once served on advisory committees for AIDS-related medicine with the Ministry ofHealth, Labor and Welfare in Japan. He also organized numerous collaborative
relationships between Japan, the United States of America, and other countries toadvance HIV care and management in Japan.
Dr. Aoki is also committed to the education and mentoring of young physicians andother healthcare professionals in the field of clinical infectious diseases in general.
In 2013, he was nominated as one of the ten founders of Japanese medicine byNikkei Medical Magazine.

Kiyosu Taniguchi, MD, PhD

Dr. Taniguchi is the Director of the Department of Clinical Research, National MieHospital, National Hospital Organization in Mie, Japan.
Dr. Taniguchi graduated from the School of Medicine at National Mie University in
1984, and had been trained and worked as a pediatrician at several hospitals for 15years. Between 1992 and 1995, he engaged in the international collaboration
research project in Noguchi Memorial Institute for Medical Research in Ghana.
In 1996, he joined the National Institute of Infectious Diseases (NIID), Tokyo, Japanand had committed the establishment of Infectious Disease Surveillance Center andengaged in the national infectious disease surveillance system and FETP. In 2000,
he was dispatched to WHO/HQ/CDS/CSR and worked for international infectious
disease surveillance and control program including GOARN and IHR. After comingback to Infectious Disease Surveillance Center, NIID in 2002, he resumed theactivities on national infectious disease surveillance and response and experienced
a lot of infectious disease outbreaks including SARS, pandemic 2009 and so on.
In 2013, he left NIID and started working at current institution, where in addition to
the clinical practice as a pediatrician, he continues to work in the research field on
vaccine preventable diseases, surveillance and epidemiology of infectious diseases
and various international research program.

Kentaro Iwata, MD, PhD, MSc, FACP, FIDSA, CTH, CIC

Dr. Kentaro Iwata is Professor of Infectious Diseases Risk Communication at theResearch Center for Urban Safety and Security, Infectious Diseases Therapeutics ofKobe University Graduate School of Medicine. He also serves as the Chief of theDivision of Infectious Diseases as well as the Division of International Healthcare at
Kobe University Hospital in Hyogo, Japan.

Hajime Kamiya, MD, MPH, PhD

Dr. Hajime Kamiya is the Senior Researcher and Medical Officer at the Infectious
Disease Surveillance Center, National Institute of Infectious Diseases in Tokyo,
Japan.
Dr. Kamiya is a native of Japan. He graduated Mie University School of Medicine in1999 and trained as a pediatrician at St.Luke’s International Hospital in Tokyo. He
was board certificated in pediatrics in 2004.
His interest in immunization posted him to a research fellow at University ofCalifornia San Diego (UCSD), Department of Pediatrics, with the County of San
Diego Health and Human Services Agency, Immunization Branch (SDIB). Since
2006, he became graduate student at Rollins School of Public Health, Emory
University, Atlanta GA, where he learned the fundamental of epidemiology.
After graduating from Emory University, he joined National Institute of Infectious
Diseases, Infectious Disease Surveillance Center in Tokyo as a researcher. In 2012,
Dr. Kamiya was accepted as Epidemiology Intelligence Service (EIS) officer atCenter for Diseases Control and Prevention (CDC). He was assigned to Meningitis
and Vaccine Preventable Disease Branch (MVPDB) and experienced outbreak
investigation, evidence based policy making, the strategic planning, interventions
and evaluation of the immunization program from a federal government aspect.
Dr. Kamiya returned to his old position in July 2014. Based on his experiences inthe United States, Dr. Kamiya is directing his training to be a specialist inimmunization field.

Report on "How Does Politics Influence Global Health Policy?: AntimicrobialResistance (AMR) and Pandemic Influenza" (February 27, 2018)
February 27, 2018
Report on the iGHP Special Seminar"How Does Politics Influence Global Health Policy?: Antimicrobial Resistance (AMR)
and Pandemic Influenza"
On February 27, 2018, the Disease Control and Prevention Center (DCC) of NCGM
and iGHP had the honor to host a special lecture by Professor Keiji Fukuda,
Director and Clinical Professor at the University of Hong Kong School of Public
Health. The lecture covered a holistic history of infectious disease control as well as
Prof. Fukuda’s own experiences battling various challenging issues at the global
policy level. Throughout his lecture, Prof. Fukuda emphasized some essential
requirements for working in the field of global health policy: 1) understanding
relevant contexts; 2) identifying underlying issues; 3) focusing on mutual interests;4) the importance of building trust with partners to achieve common goals.
Prof. Fukuda’s comprehensive and informative lecture was followed by an inspiring
panel discussion among leading Japanese experts who have extensive knowledge
and experiences in clinical practice, research, education, and domestic andinternational health policy in the fields of infectious diseases and epidemiology.
Their intriguing discussion topics included, for example, the needs for field
epidemiologists in Japan, the importance of disease surveillance and utilization ofquality data, the indispensability of evidence-based and outcome-based policies andAMR management, as well as the role political initiative has played in making
vaccine recommendations in Japan.
This event was well-received by approximately eighty participants from various
academic and professional backgrounds.
Speakers:
Keiji Fukuda, Director and Clinical Professor, School of Public Health, the Universityof Hong Kong
Kuniaki Miyake, Director, Tuberculosis and Infectious Diseases Control Division,
Health Service Bureau, MOHLW, Japan

Norio Ohmagari, Director, Disease Control and Prevention Center, NCGM
Eiji Hinoshita, Director-General, Bureau of International Health Cooperation, NCGM
Panel Discussion
Moderator:
Makoto Aoki, Free-lance infectious disease consultant, Adjunct Professor ofMedicine, Tokyo Medical University
Panelists:Kiyosu Taniguchi, Director, Department of Clinical Research, National Mie Hospital,National Hospital Organization, Mie, Japan
Kentaro Iwata, Professor, Kobe University Graduate School of Medicine and Chief,
Division of Infectious Diseases and Division of International Healthcare, Kobe
University Hospital, Hyogo, Japan
Hajime Kamiya, Senior Researcher, Medical Officer, Infectious Disease SurveillanceCenter, National Institute of Infectious Diseases, Tokyo, Japan